
Loading, please wait...

Loading, please wait...

Probiotics for atopic dermatitis (AD) represent a promising area of pediatric research. A recent umbrella meta-analysis, encompassing 22 systematic reviews, highlights significant benefits for children and infants. Specifically, researchers observed that probiotic supplementation notably reduces both the severity and the incidence of AD. Although individual meta-analyses previously yielded conflicting results, this comprehensive review provides clearer clinical evidence for practitioners.
Notably, the study found a weighted mean difference (WMD) of -4.16 in disease severity scores. This reduction suggests a clinically significant improvement in skin symptoms for affected children. Furthermore, the analysis demonstrated a 23% reduction in the incidence of atopic dermatitis (RR = 0.77). These results reinforce the potential of probiotics to serve as an effective preventive measure. Consequently, early intervention might offer long-term dermatological protection for high-risk infants.
While the evidence for skin conditions is strong, findings for other atopic manifestations remain inconclusive. For example, the researchers found no significant impact on the risk of wheezing or asthma. Additionally, the efficacy of probiotics for food allergies and allergic rhinitis remains uncertain. Therefore, clinicians should focus primarily on dermatological outcomes when recommending these supplements. More research is necessary to define the optimal strains and dosages for systemic allergic prevention.
While studies show a significant reduction in incidence, the effectiveness depends on timing and high-risk status. Early prenatal and postnatal supplementation typically yields the best results.
Evidence suggests that multi-strain formulations and Lactobacillus species are particularly effective for reducing disease severity. However, individual patient responses may vary.
Currently, meta-analyses do not show a significant reduction in the risk of asthma or wheezing through probiotic use. Their primary proven benefit remains focused on atopic dermatitis.
Disclaimer: This content is for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for consultation with a healthcare professional. Always seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Rafiei Z et al. Probiotic Supplementation and Its Impact on Atopic Dermatitis and Related Conditions in Infants and Children: An Umbrella Review of Systematic Reviews with Meta-Analyses. Probiotics Antimicrob Proteins. 2026 Feb 28. doi: 10.1007/s12602-025-10738-5. PMID: 41762435.
Wang Y, Xu X. The impact of prebiotics, probiotics and synbiotics on the prevention and treatment of atopic dermatitis in children: an umbrella meta-analysis. Front Nutr. 2025 Mar 21;12:1587348.
Zhong L, Su J, Zhou X, Wan H. Probiotics supplements for the prevention of atopic dermatitis in children: an umbrella review. Front Nutr. 2025 Jul 15;12:1587348.

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


An umbrella meta-analysis of 22 systematic reviews shows probiotics significantly reduce atopic dermatitis severity and incidence in children....
6 months ago

Explore the emerging role of Brixadi, an extended-release buprenorphine injection, for managing stimulant use disorder through kappa opioid receptor antagonism and steady plasma levels.
Today

A premature neonate developed upper limb compartment syndrome after uterine rupture extruded the arm through a scar defect. Conservative management with continuous monitoring yielded complete functional recovery and normal limb growth at 10-year follow-up, highlighting non-operative safety in selected cases.
Today

Dendritic cells bridge innate and adaptive immunity in myocardial infarction. This review explores their pathological roles, circulating dynamics, novel tolerogenic interventions, and how standard cardiovascular medications modulate dendritic cells to improve post-infarction myocardial repair and patient outcomes.
Today

Endoscopic posterior cervical fusion combines minimally invasive decompression, joint preparation, and rigid screw-rod fixation for atlantoaxial pathologies. Early clinical findings demonstrate solid bony union, excellent symptom relief, and minimal soft-tissue morbidity without significant vascular compromise.
Yesterday

Atherosclerosis involves extensive glycometabolic reprogramming across immune and vascular cells. This review examines how glycolysis, the pentose phosphate pathway, and lactate-driven epigenetic shifts fuel plaque vulnerability, while highlighting novel therapeutic targets like PFKFB3 and LDHA.
Today